About VNH Pharmaceuticals Private Limited
Data last updated:
VNH Pharmaceuticals Private Limited is a private limited company based in Shameerpet, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2017PTC117352. Its GSTIN is 36AAFCV9393K1ZI (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mora Suman Kumar and Kalpana Ravanaboina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Biotech Park, Shameerpet, Telangana.
As per the financials filed for FY 2021, the company reported a revenue of ₹60.62 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹2.45 Lakh (net margin 4%) and EBITDA of ₹3.39 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vnhpharma.com.
Company details
Contact details
VNH Pharmaceuticals Private Limited's registered office is in Shameerpet, Telangana. Its website is vnhpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBuilding Cronies Plot No. 4C Mn Sc. Biotech Park Genome Valley Synergy Square – 1 Ph – 1 Turkapally, Shamirpet Medchal Malkajgiri Rangareddi, Shameerpet, Telangana, India – 500078
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of VNH Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of VNH Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of VNH Pharmaceuticals Private Limited, buy the company report.
Financials of VNH Pharmaceuticals Private Limited
FY 2025 filings availableVNH Pharmaceuticals Private Limited reported revenue of ₹60.62 Lakh (down 38% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 38% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA fell 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.39 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.45 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.6% | |||
| Net Profit Margin | 4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of VNH Pharmaceuticals Private Limited, buy the company report.
Board of directors of VNH Pharmaceuticals Private Limited
VNH Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mora Suman Kumar | Director | 25 May 2017 | 9 Years 5 Months | Current |
| Kalpana Ravanaboina | Director | 25 May 2017 | 9 Years 5 Months | Current |
| Santosh Kumar Boddu Also directs: Vnh-P Pharmaceuticals Private Limited, Vaidyo Narayano Hari Pharmaceuticals Private Limited, Chinmayi Wealth Experts LLP and 2 more | Director | 25 May 2017 | 9 Years 5 Months | Current |
| Mateti Srinivas | Director | 25 May 2017 | 9 Years 5 Months | Current |
Peer comparison
VNH Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Million Pharmaceuticals Private Limited | ₹60.92 Lakh (FY 2017) | -2.0% | Muktsar, Punjab, India | |||
| Mednios Pharmaceuticals Private Limited | ₹60.84 Lakh (FY 2025) | 32.0% | Patna, Bihar, India | |||
| VNH Pharmaceuticals Private Limitedthis company | ₹60.62 Lakh (FY 2021) | ₹2.45 Lakh | 4% | -38.0% | Shameerpet, Telangana, India | |
| Meglife Pharmaceuticals Private Limited | ₹60.21 Lakh (FY 2025) | 3.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of VNH Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VNH Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VNH Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
VNH Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCV9393K1ZI | Telangana | Active | 06 Oct 2017 |
To see the full GST registrations and return filing status of VNH Pharmaceuticals Private Limited, buy the company report.
Recent activity
VNH Pharmaceuticals Private Limited has 8 board changes on record since 2017: 6 appointments and 2 cessations. The latest: Rajamouli Katukuri ceased to be Director on 03 Jan 2018.
Frequently asked questions
VNH Pharmaceuticals is an active private limited company based in Shameerpet, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 May 2017 (9+ years old) and is registered under CIN U24290TG2017PTC117352.
VNH Pharmaceuticals has 4 current directors:
- Mora Suman Kumar - Director
- Kalpana Ravanaboina - Director
- Santosh Kumar Boddu - Director
- Mateti Srinivas - Director
The latest financial statements of VNH Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of VNH Pharmaceuticals is 36AAFCV9393K1ZI, registered in Telangana.
The CIN (Corporate Identification Number) of VNH Pharmaceuticals is U24290TG2017PTC117352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VNH Pharmaceuticals was incorporated on 25 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of VNH Pharmaceuticals by revenue are Million Pharmaceuticals Private Limited, Mednios Pharmaceuticals Private Limited, Meglife Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajamouli Katukuri ceased to be Director on 03 Jan 2018. Rajender Kajampuram ceased to be Director on 03 Jan 2018. Kalpana Ravanaboina was appointed as Director on 25 May 2017. VNH Pharmaceuticals has 8 board changes on record in total.
VNH Pharmaceuticals can be reached through the website vnhpharma.com. Its registered office is in Shameerpet, Telangana, India.
The registered office of VNH Pharmaceuticals is at Building Cronies Plot No. 4C Mn Sc. Biotech Park Genome Valley Synergy Square – 1 Ph – 1 Turkapally, Shamirpet Medchal Malkajgiri Rangareddi, Shameerpet, Telangana, India – 500078.
VNH Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
